118 related articles for article (PubMed ID: 32558282)
1. Bioinformatic Identification of a Breast-Specific Transcript Profile.
Chen C; Yang L; Rivandi M; Franken A; Fehm T; Neubauer H
Proteomics Clin Appl; 2020 Nov; 14(6):e2000007. PubMed ID: 32558282
[TBL] [Abstract][Full Text] [Related]
2. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S
Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380
[TBL] [Abstract][Full Text] [Related]
3. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
[TBL] [Abstract][Full Text] [Related]
4. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
[TBL] [Abstract][Full Text] [Related]
5. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of prognostic value of
Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
[No Abstract] [Full Text] [Related]
7. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
8. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.
Ching T; Peplowska K; Huang S; Zhu X; Shen Y; Molnar J; Yu H; Tiirikainen M; Fogelgren B; Fan R; Garmire LX
EBioMedicine; 2016 May; 7():62-72. PubMed ID: 27322459
[TBL] [Abstract][Full Text] [Related]
10. BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis.
Barton M; Santucci-Pereira J; Vaccaro OG; Nguyen T; Su Y; Russo J
BMC Cancer; 2019 Oct; 19(1):994. PubMed ID: 31646972
[TBL] [Abstract][Full Text] [Related]
11. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
Liu XM; Yang B; Han J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
[TBL] [Abstract][Full Text] [Related]
13. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Bouchal P; Dvořáková M; Roumeliotis T; Bortlíček Z; Ihnatová I; Procházková I; Ho JT; Maryáš J; Imrichová H; Budinská E; Vyzula R; Garbis SD; Vojtěšek B; Nenutil R
Mol Cell Proteomics; 2015 Jul; 14(7):1814-30. PubMed ID: 25903579
[TBL] [Abstract][Full Text] [Related]
14. Screening of Prognostic Factors in Early-Onset Breast Cancer.
Yu Z; He Q; Xu G
Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
[TBL] [Abstract][Full Text] [Related]
17. MUC14-Related ncRNA-mRNA Network in Breast Cancer.
Wang S; Jin J; Chen J; Lou W
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828282
[No Abstract] [Full Text] [Related]
18. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
19. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
[TBL] [Abstract][Full Text] [Related]
20. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S
Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
